Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) ("DelphX"), a leader in the development of new classes of structured products, announces that it intends to proceed with a non-brokered private placement ("the Offering") of 2,800,000 units (the "Units") at a subscription price of C$0.04 per Unit, for gross proceeds of C$112,000. Each Unit will consist of one common share ("Common Share") and one Common Share purchase warrant ("Warrant"). Each W ...

Group 1 - DelphX Capital Markets Inc. has closed a non-brokered private placement, issuing 1,500,000 units at a subscription price of C$0.05 per unit, resulting in gross proceeds of C$75,000 [1] - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of one common share at a price of $0.08 for two years [1] - An insider subscribed for 1,000,000 units, classifying the offering as a "related party transaction" under MI 61-101, but exemptions were relied upon as the transaction did not exceed 25% of DelphX's market capitalization [2] Group 2 - DelphX will pay cash finder's fees of $3,500 and issue 70,000 finder's warrants to AlphaNorth Asset Management, with the finder's warrants exercisable at $0.08 for two years [3] - The completion of the offering is subject to TSX Venture Exchange approval, and the securities will be under a hold period of four months plus one day from issuance [3] Group 3 - The net proceeds from the offering will be used for general corporate purposes [4] - DelphX focuses on developing and distributing next-generation structured products, including collateralized put options (CPOs) and collateralized reference notes (CRNs) [5][7] - CPOs provide secured rating downgrade protection for corporate bonds and cryptocurrency holdings, while CRNs offer capped exposure to rating downgrades and cryptocurrency losses in exchange for attractive returns [7]

Core Viewpoint - DelphX Capital Markets Inc. is seeking approval from the TSX Venture Exchange to extend the exercise period of certain share purchase warrants by one year, which indicates a strategic move to provide more flexibility for investors [1][2]. Group 1: Warrant Details - The company intends to extend the exercise period of 4,825,715 share purchase warrants, originally exercisable at $0.30 per common share, to August 25, 2026 [2]. - Additionally, 2,825,000 share purchase warrants, exercisable at $0.15 per common share, will also have their exercise period extended to August 30, 2026 [2]. - All other terms and conditions of the warrants will remain unchanged, and the extension is subject to acceptance by the TSX Venture Exchange [3]. Group 2: Related Party Transactions - A total of 1,929,286 warrants are held by parties considered "related parties" of DelphX, making the amendment a "related party transaction" under relevant regulations [4]. - The company can rely on exemptions from formal valuation and minority approval requirements since the fair market value of the warrants does not exceed 25% of DelphX's market capitalization [4]. Group 3: Company Overview - DelphX is focused on developing and distributing next-generation structured products, including collateralized put options (CPOs) and collateralized reference notes (CRNs) [5][8]. - The company enables broker-dealers to offer new private placement securities that provide fixed income and cryptocurrency solutions [5]. - CPOs and CRNs are fully collateralized and held in custody by US Bank, showcasing the company's commitment to security and reliability in its offerings [6][8].